Piper Jaffray Downgrades Imprivata (IMPR) to Neutral

Go back to Piper Jaffray Downgrades Imprivata (IMPR) to Neutral

Imprivata Agrees to Be Acquired by Thoma Bravo

July 13, 2016 8:00 AM EDT

Thoma Bravo to pay $19.25 per share, representing a 33% premium to Imprivatas stock price

Transaction valued at approximately $544 million

SAN FRANCISCO & LEXINGTON, Mass.--(BUSINESS WIRE)-- Imprivata® (NYSE: IMPR), the healthcare IT security company, announced that it has entered into a definitive agreement to be acquired by an affiliate of Thoma Bravo, LLC, a leading private equity investment firm. Under the terms of the agreement, shareholders of record will receive $19.25 in cash per share of Imprivata common stock, which represents a 33% premium to Imprivatas last closing... More